Since then, the expression of MTUS1 has been shown to be down-regulated in breast cancer, colon tumors, prostate cancer cell lines, ovarian cancer and head and neck squamous cell carcinoma, implicating a role in a wide range of cancer development (5–10). Here, MTUS1 is linked to ovarian carcinoma.